A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Big deal: Nightstar shines bright in $800m acquisition Nightstar Therapeutics, based on Oxford research, stands to receive $800m from Biogen in an acquisition deal that comes a year and a half after completing a $75m IPO. Imperial internalises tech transfer ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.